SV Health Investors’s Tectonic Therapeutic TECX Stock Holding History

SV Health Investors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,920	Closed	-$3.49M	–	8
2021 Q1	$3.49M	Sell	22,920 -76,386	-77%	-$12.4M	1.31%	6
2020 Q4	$16.6M	Sell	99,306 -3,704	-4%	-$658K	8%	7
2020 Q3	$16.1M	Hold	103,010	–	–	8.15%	7
2020 Q2	$21.6M	Hold	103,010	–	–	14.96%	4
2020 Q1	$19.2M	Sell	103,010 -15,090	-13%	-$3.55M	16.13%	2
2019 Q4	$28.5M	Hold	118,100	–	–	17.28%	3
2019 Q3	$20M	Sell	118,100 -42,792	-27%	-$9.69M	14.06%	3
2019 Q2	$31.4M	Hold	160,892	–	–	21.07%	2
2019 Q1	$42.6M	Sell	160,892 -67,110	-29%	-$12.3M	24.97%	2
2018 Q4	$45.6M	Hold	228,002	–	–	28.05%	2
2018 Q3	$142M	Hold	228,002	–	–	41.55%	1
2018 Q2	$78.1M	Buy	+228,002	New	+$82.2M	35.88%	1

Other funds holding TECX

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SV Health Investors's TECX Position: Q2 2021 in Review

SV Health Investors sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 22,920 shares — an estimated $3.49M sold.

SV Health Investors first reported a position in TECX in Q2 2018 and held it in 12 quarters. The position peaked at $142M in Q3 2018. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

SV Health Investors reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
SV Health Investors sold 22,920 Tectonic Therapeutic shares in Q2 2021, an estimated $3.49M.
SV Health Investors first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 12 quarters.
SV Health Investors's Tectonic Therapeutic position peaked at $142M in Q3 2018.
97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on SV Health Investors's 13F filing for Q2 2021, filed 16 Aug 2021.